FDA approves Nexavar to treat type of thyroid cancer

The U.S. Food and Drug Administration today expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer.

Home | Copyright 2008-2024 FoodandDrugRecall.org